An Essential Partnership: Patient Advocates and Cooperative Groups

References 

1. Collyar DE. How have patient advocates in the United States benefited cancer research?. Nature Rev Cancer. 2005;5:73–78
2. Demmy TL, Yasko JM, Collyar DE, Katz ML, Krasnov CL, Borwhat MJ. Managing accrual in cooperative group clinical trials. J Clin Oncol. 2004;22:2997–3002
   • MEDLINE
   • CrossRef
3. Collyar D. Connecting clinical trials to people. National Cancer Policy Forum (NCPF) Multi-site Clinical Trials and the National Cancer Institute Cooperative Group Program: A Workshop. July 1-2, 2008. Institute of Medicine. http://www.iom.edu/CMS/26765/52301/54763.aspxAccessed July 30, 2008
4. The International Myeloma Foundation says ECOG results could improve survival while reducing side effects for many patients. http://myeloma.org/main.jsp?type=article&id=2056Accessed February 1, 2008
5. Michaels M, Collyar D. Research advocacy in traditional research settings: questions of influence and legitimacy. In:  Earp JA,  French EA,  Glikey MB editor. Patient advocacy for health care quality. Sudbury, MA: Jones & Barlett; 2007;p. 445–478